RTC
UTMD icon

Riverview Trust Company’s Utah Medical Products UTMD Stock Holding History

Riverview Trust Company’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-15
Closed -$1K – 403
2019
Q1 		$1K Buy
+15
New +$1.32K ﹤0.01% 438

Other funds holding UTMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Riverview Trust Company's UTMD Position: Q2 2019 in Review

Riverview Trust Company sold out of Utah Medical Products (UTMD) in Q2 2019, closing a stake of 15 shares — an estimated $1K sold.

Riverview Trust Company first reported a position in UTMD in Q1 2019 and held it in 1 quarter. The position peaked at $1K in Q1 2019. 98 funds tracked by Wall St. Rank hold UTMD as of Q2 2019.

  • Riverview Trust Company reported no remaining Utah Medical Products position as of Q2 2019 after selling out during the quarter.
  • Riverview Trust Company sold 15 Utah Medical Products shares in Q2 2019, an estimated $1K.
  • Riverview Trust Company first reported a position in Utah Medical Products in Q1 2019 and held it in 1 quarter.
  • Riverview Trust Company's Utah Medical Products position peaked at $1K in Q1 2019.
  • 98 funds tracked by Wall St. Rank held Utah Medical Products as of Q2 2019.

Based on Riverview Trust Company's 13F filing for Q2 2019, filed 12 Jul 2019.